shutterstock_110597087-web

Computational modelling predicts liver toxicity effects of 15 drugs

February 7, 2017
Research and Development modelling

A team from Germany’s RWTH Aachen University, in collaboration with two researchers from Wellcome Genome Campus in the UK, have …

mylan

Mylan pays $96.5 million to settle pay-for-delay case

February 7, 2017
Research and Development, Sales and Marketing Cephalon, Mylan, Teva, antitrust

Mylan has agreed to pay $96.5 million in order to settle an antitrust case. The case was related to the …

european_patent_office_munich-sign

New EPO regulations bad for biotech innovation, experts claim

February 7, 2017
Manufacturing and Production, Sales and Marketing EPO, IFPMA, SMEs, biotech

A recently-adopted initiative by the European Patent Office (EPO) to reduce patient examination times could lead to a stagnation of …

mosquito

Abbott’s Zika virus test given FDA authorisation

February 7, 2017
Manufacturing and Production, Research and Development Abbott Laboratories, Zika virus

The threat of the Zika virus, though it may have disappeared from the headlines, is still very much present. Any …

thomas-cueni

Thomas Cueni named as new IFPMA Director General

February 7, 2017
Manufacturing and Production IFPMA

Thomas Cueni has become the new Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and will …

erez_vigodman

Teva’s CEO merry-go-round continues as Vigodman leaves

February 7, 2017
Manufacturing and Production, Medical Communications Teva, erez vigodman

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …

keytruda3-web

MSD aims to get the jump on BMS treating bladder cancer

February 6, 2017
Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, MSD, keytruda, opdivo

Bristol-Myers Squibb’s Opdivo was only just approved for second-line treatment of bladder cancer, but MSD has attempted to have its …

hugo_fry

Sanofi reinforces senior staff with two new execs

February 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …

ken_cunningham

Medherant appoints new Chairman

February 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medherant

Medherant has brought in Dr Ken Cunningham as Chair in a bid to strengthen the company as it moves into …

johnson_and_johnson_jj

J&J breast implants “may have harmed thousands”, claims fresh lawsuit

February 6, 2017
Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants

Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …

FDA clears Opdivo to treat most common form of bladder cancer

February 6, 2017
Sales and Marketing BMS, Bristol-Myers Squibb, MSD, bladder cancer, immunotherapy, keytruda, opdivo

Bristol-Myers Squibb’s Opdivo has acquired another indication – being given the go-ahead for treatment of patients with metastatic urothelial carcinoma. …

social_media

Socially vigilant: Does pharmacovigilance need secondary data & social media?

February 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …

dna_research

Link discovered between immune system genes and leukaemia

February 6, 2017
Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …

innate-pharma

Phase 2 failure for Innate Pharma leukaemia drug

February 6, 2017
Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …

computer_doctor

10% of UK left with no out-of-hours GP cover during 2016

February 6, 2017
Medical Communications, Sales and Marketing

A freedom of information request, by Pulse, led to the discovery that 1 in 10 areas in the UK were …

cancer-389921_960_720

Cancer rates set to rocket in women six times faster than men

February 3, 2017
Medical Communications, Research and Development Cancer, Cancer Research UK, World Cancer Day

The figures emerging from research conducted by Cancer Research UK predict that rates of cancer in women will rise by …

r3ws8b7e-web

Takeda discusses the importance of patient-focused market access

February 3, 2017
Medical Communications, Sales and Marketing Takeda, oncology

With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Moving into February,and the first weeks of Trump’s term, the US President has dominated the headlines in the industry as …

pills

Study reveals antidepressant medication’s action upon brain

February 3, 2017
Medical Communications, Research and Development antidepressants, mental health, research

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …

shutterstock_57369385

WCO seizes 113m fake Indian & Chinese drugs in Africa in 10 days

February 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Africa, China, Counterfeit drugs, India, World Customs Organisation

The World Customs Organisation (WCO) has revealed insight into the extent of the global drug counterfeiting crisis with the announcement …

The Gateway to Local Adoption Series

Latest content